Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

AI Assistance for Clinicians Identifying Causes of Chest Pain From ECG Images

12. November 2026 aktualisiert von: Shenda Hong, Peking University Health Science Center

A Two-Arm Parallel-Group Randomized Trial of ZERO-Assisted and Unassisted Clinicians Identifying Causes of Chest Pain From Real-World ECG Images

This study will assess whether reports generated by ZERO, a mobile system for interpreting electrocardiogram (ECG) images, improve clinicians' ability to identify causes of chest pain compared with interpretation without AI assistance.

A total of 120 licensed cardiology clinicians will be randomly assigned in a 1:1 ratio to ZERO-assisted or unassisted interpretation. Each clinician will assess 30 ECG cases during a single session lasting up to 60 minutes. The cases will include five examples from each of six diagnostic categories: unstable angina, non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, aortic dissection, pulmonary embolism, and other diagnoses. No case or patient will be repeated within or across clinicians.

For each case, clinicians will first review the ECG and submit an initial diagnosis that cannot subsequently be changed. Clinicians in the ZERO-assisted group will then view a fixed report generated before clinician randomization. Clinicians in the unassisted group will review the ECG again without an AI report. All clinicians will then submit a final diagnosis.

Diagnostic performance will be assessed against clinical reference diagnoses established before the interpretation task and withheld from participating clinicians. The study will use ECG cases from completed clinical encounters and will not affect patient care. The hypothesis is that ZERO-assisted clinicians will achieve higher final diagnostic accuracy than unassisted clinicians.

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Intervention / Behandlung

Studientyp

Interventionell

Einschreibung (Geschätzt)

120

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 110 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Licensed cardiology clinicians who routinely participate in the diagnosis or management of chest pain or cardiovascular disease and interpret electrocardiograms (ECGs).
  • Able to read Chinese-language reports and use the study platform.
  • Willing to provide electronic informed consent and sign a confidentiality statement.
  • Willing to complete all 30 assigned ECG interpretation tasks within the specified study period.

Exclusion Criteria:

  • Access to the reference diagnoses of the study cases, or involvement in screening, selecting, or adjudicating these cases.
  • Prior knowledge of the answers to the study cases through participation in model development or previous experiments.
  • Duplicate enrollment.
  • Inability to complete training in the use of the study platform.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Diagnose
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Kein Eingriff: No AI Assistance

Clinicians will interpret 30 unique ECG cases, with five cases from each diagnostic category, during a single session lasting up to 60 minutes. For each case, clinicians will review the ECG image and submit an initial first-choice diagnosis, which will then be locked. They will subsequently review the same ECG image again without an AI report and submit a final first-choice diagnosis, which will also be locked.

Experimental: ZERO Assistance

Clinicians will first review each assigned ECG image and submit and lock an initial first-choice diagnosis. They will then view the fixed ZERO-generated report and submit and lock a final first-choice diagnosis. The report will include risk alerts for STEMI, aortic dissection, and pulmonary embolism, ranked diagnostic candidates, supporting explanations and available sources, and suggestions for further evaluation. If the report is unavailable or invalid, the failure will be recorded and the clinician may still submit a final diagnosis. Each clinician will complete 30 unique cases, with five cases per diagnostic category.

ZERO is a mobile system that processes de-identified ECG images and generates structured diagnostic reports. It integrates image preprocessing, a dedicated prediction model, risk stratification, knowledge retrieval, and report generation using GLM-4.6. Reports will be generated and stored before clinician randomization using a prespecified, frozen model, prompts, and retrieval configuration. During the interpretation task, the corresponding report will be displayed only after the clinician has submitted and locked the initial diagnosis. No additional patient information or clinician responses will be supplied to the system, and reports will not be modified during the task. No online adaptation will occur during the study.

Andere Namen:
  • ZERO

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Finalfirst-choice diagnostic accuracy
Zeitfenster: 60 Minutes

For each clinician, final first-choice diagnostic accuracy will be calculated as the number of cases in which the final first-choice diagnosis matches the prespecified clinical reference diagnosis, divided by 30 and multiplied by 100%. Each clinician will assess five cases from each of six diagnostic categories. The outcome will be summarized as the mean clinician-level accuracy in each randomized group. Only clinicians with both an initial and a final diagnosis recorded for all 30 cases will be included in the diagnostic outcome analysis. The primary comparison will be between the ZERO-assisted and unassisted groups.

60 Minutes

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Final Missed-Diagnosis Percentage for ST-Segment Elevation Myocardial Infarction
Zeitfenster: 60 Minutes

Among clinicians with complete initial and final diagnoses for all 30 cases, the percentage of cases with a reference diagnosis of ST-segment elevation myocardial infarction for which the final first-choice diagnosis is not ST-segment elevation myocardial infarction. Each clinician's percentage will be calculated as the number of such cases divided by five and multiplied by 100%. The outcome will be summarized as the mean clinician-level percentage in each randomized group. Lower values indicate fewer missed diagnoses in the ECG interpretation task.

60 Minutes
Final Missed-Diagnosis Percentage for Aortic Dissection
Zeitfenster: 60 Minutes

Among clinicians with complete initial and final diagnoses for all 30 cases, the percentage of cases with a reference diagnosis of aortic dissection for which the final first-choice diagnosis is not aortic dissection. Each clinician's percentage will be calculated as the number of such cases divided by five and multiplied by 100%. The outcome will be summarized as the mean clinician-level percentage in each randomized group. Lower values indicate fewer missed diagnoses in the ECG interpretation task.

60 Minutes
Final Missed-Diagnosis Percentage for Pulmonary Embolism
Zeitfenster: 60 Minutes

Among clinicians with complete initial and final diagnoses for all 30 cases, the percentage of cases with a reference diagnosis of pulmonary embolism for which the final first-choice diagnosis is not pulmonary embolism. Each clinician's percentage will be calculated as the number of such cases divided by five and multiplied by 100%. The outcome will be summarized as the mean clinician-level percentage in each randomized group. Lower values indicate fewer missed diagnoses in the ECG interpretation task.

60 Minutes
Proportion of Cases Revised From an Incorrect to a Correct Diagnosis
Zeitfenster: 60 Minutes

For each clinician, the proportion will be calculated as the number of cases in which the initial first-choice diagnosis does not match the reference diagnosis but the final first-choice diagnosis does match it, divided by 30 and multiplied by 100%. The outcome will be summarized as the mean clinician-level proportion in each randomized group. The analysis will include only clinicians with complete initial and final diagnoses for all 30 assigned cases. Higher values indicate that more cases were corrected during the second assessment.

60 Minutes
Proportion of Cases Revised From a Correct to an Incorrect Diagnosis
Zeitfenster: 60 Minutes

For each clinician, the proportion will be calculated as the number of cases in which the initial first-choice diagnosis matches the reference diagnosis but the final first-choice diagnosis does not match it, divided by 30 and multiplied by 100%. The outcome will be summarized as the mean clinician-level proportion in each randomized group. The analysis will include only clinicians with complete initial and final diagnoses for all 30 assigned cases. Lower values indicate that fewer initially correct diagnoses became incorrect during the second assessment.

60 Minutes

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

19. November 2026

Primärer Abschluss (Geschätzt)

11. Dezember 2026

Studienabschluss (Geschätzt)

18. Dezember 2026

Studienanmeldedaten

Zuerst eingereicht

12. November 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

12. November 2026

Zuerst gepostet (Tatsächlich)

18. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

18. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

12. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • ZERO-RCT26001

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .